INDIA - 2024/11/06: In this photo illustration, a HIMS logo seen displayed on a smartphone and in ... [+] the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of Eli Lilly’s weight loss drug – Zepbound. The shortage of GLP-1 drugs bodes w ...

公司评论 第一上海研究部 research@firstshanghai.com.hk | --- | --- | --- | |------------------------------------|----------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Hims & Hers has given back recent gains, but don't overlook the company's massive growth.Shares of Hims & Hers (HIMS -7.34%) is down big this week after Amazon (AMZN -4.19%) announced its expansion into telehealth. The market thinks this is terrible news, but is it? Travis Hoium covers the industry dynamics in this video.*Stock prices used were end-of-day prices of Nov. 14, 2024. The video was published on Nov. 14, 2024. ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

Hims & Hers (NYSE: HIMS ) has attracted much investor interest this year due to its accelerating revenue growth and rapidly improving profitability. The stock soared 134% up until November 14, compared to the S&P 500's ( I have been a Merchant Seaman that has traveled the world for over 30 years. Within the last 15 years, I developed a very intense interest in investing. I learned a lot of what I know about investing from The MF. Also because I have a engineering background, I often tend to gravitate to Tec ...

Hims & Hers Health, Inc.’s (HIMS) investors are reaping some gains from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have gained 31.1% since Nov. 1, outperforming the industry’s 14.6% gain. In the same time frame, the stock outperformed the sector and S&P 500’s 0.6% decline and 4.6% growth, respectively. The company reported its third-quarter 2024 earnings on Nov. 4.Another major development from HIMS in recent months includes the announcement of access to the most c ...

The healthcare company is on fire, and it's still cheap by many measures.Shares of Hims & Hers Health (HIMS 19.09%) have been on fire over the past year, but they're not expensive by most valuation metrics, especially when you consider the company's high growth rate. How much room is left to run? That's what Travis Hoium discusses in this video.*Stock prices used were end-of-day prices of Nov. 11, 2024. The video was published on Nov. 11, 2024. ...

My goal is to help you find the companies of tomorrow.I am a long-term growth investor in search of innovative companies that make the world a better place. My investment strategy revolves around finding what I call "divergent stocks" — disruptive companies that have strong fundamentals and long growth runways, but depressing prices.You can find me on YouTube as well:https://www.youtube.com/@riyadosofianAnalyst’s Disclosure: I/we have a beneficial long position in the shares of HIMS, PLTR either through sto ...

Editor's note: Seeking Alpha is proud to welcome Julian Fuchs as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.As a 20-year-old student passionate about stock analysis, I provide in-depth equity research and market insights. With a solid grasp of financial trends, I aim to offer actionable investment ideas and identify growth and value opportunities. F ...

Hims & Hers Health, Inc. (HIMS) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings e ...